Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Anti-Microbial Savior Bioteq Co. Ltd. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This 1 action is assigned to 1 distinct examiner and 1 distinct art unit. BURKE, MATTHEW RYAN is the busiest examiner for the portfolio, responsible for the 1 busiest examiner pending action. The alignment of the pending office action count with the workload of 1 examiner suggests that the company's current interactions with the patent office are limited to a specific technical inquiry.
Practitioners should note that with 1 distinct examiner involved, the prosecution of the current portfolio depends on the individual examination style of BURKE, MATTHEW RYAN. The presence of 1 distinct art unit confirms that the company is navigating 1 regulatory framework within the office. Because the number of pending actions is identical to the number of distinct examiners, there is no internal baseline for comparing examiner behavior within this portfolio. Consequently, the prosecution strategy is tailored to the feedback provided in the 1 pending office action currently on record. The focus on Biotechnology & Pharmaceuticals ensures that the action is subject to the specific guidelines of that technology area.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BURKE, MATTHEW RYAN | 1 | 0.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18825018 | ARTIFICIAL DRESSING, USE OF ARTIFICIAL DRESSING FOR PROMOTING WOUND HEALING AND METHOD OF MANUFACTURING ARTIFICIAL DRESSING | BURKE, MATTHEW RYAN | — |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18825018 | ARTIFICIAL DRESSING, USE OF ARTIFICIAL DRESSING FOR PROMOTING WOUND HEALING AND METHOD OF MANUFACTURING ARTIFICIAL DRESSING | BURKE, MATTHEW RYAN | 1619 | §103 | Non-Final OA | — | Pending | Sep 05, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAnti-Microbial Savior Bioteq Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Matthew Ryan Burke has the most, with 1 of Anti-Microbial Savior Bioteq Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
